EVMN · Evommune, Inc. · Proposed Sales
$7.04
-0.20 (-2.76%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$291.10M
Shares
41.35M
Volume · Nov 20
549.4K
Avg daily vol (3M)
834K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-22 | JANICE DREW | Officer | 20,000 | 2026-06-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-02 | DAVID COHEN | Director | 9,258 | 2026-06-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | LUIS PENA | Director, Officer | 24,225 | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | JEEGAR PATEL | Officer | 18,175 | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-28 | GREGORY MOSS | Officer | 14,223 | 2026-05-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-28 | KYLE CARVER | Officer | 25,675 | 2026-05-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings
Key facts
CIK
2044725
CUSIP
30054Y107
13F (30d)
99 filings
97 filers
Visit website
Investor relations